PanGen Biotech Inc (222110) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

PanGen Biotech Inc (222110) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩3.22 Billion) in capital expenditures (₩56.30 Million). Check tangible net worth ratio of PanGen Biotech Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

Data as of

Jun 2025

Most recent filing

PanGen Biotech Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks PanGen Biotech Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see PanGen Biotech Inc operating cash flow efficiency.

Annual Capital Reinvestment Ratio for PanGen Biotech Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for PanGen Biotech Inc from 2024 to 2024. See 222110 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.13x	₩2.99 Billion	₩374.12 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow